Eli Lilly buys Loxo Oncology in $8 billion cancer push Eli Lilly said today it would buy Loxo Oncology for about $8 billion in cash, buying into a portfolio of targeted medicines to treat cancers caused by rare gene mutations. Business • 07 Jan 19
Eli Lilly buys Loxo Oncology in $8 billion cancer push Eli Lilly said today it would buy Loxo Oncology for about $8 billion in cash, buying into a portfolio of targeted medicines to treat cancers caused by rare gene mutations. Business • 07 Jan 19
Eli Lilly's forecast beats on strength of new drugs Eli Lilly has today forecast 2018 profit and revenue ahead of Wall Street estimates on strong demand for recently launched drugs such as Trulicity and Taltz. Business • 13 Dec 17
Eli Lilly's forecast beats on strength of new drugs Eli Lilly has today forecast 2018 profit and revenue ahead of Wall Street estimates on strong demand for recently launched drugs such as Trulicity and Taltz. Business • 13 Dec 17
Eli Lilly to invest €35m in Kinsale facility Pharmaceutical company Eli Lilly has announced an investment of €35m for a new high-tech manufacturing facility at its Kinsale campus in Co Cork. Business • 05 Apr 16
Eli Lilly to invest €35m in Kinsale facility Pharmaceutical company Eli Lilly has announced an investment of €35m for a new high-tech manufacturing facility at its Kinsale campus in Co Cork. Business • 05 Apr 16
Novartis' plan to sell unit to Eli Lilly cleared EU regulators today cleared the proposed sale of the animal health business of Swiss pharmaceutical giant Novartis to US group Eli Lilly. Business • 03 Oct 14
Novartis' plan to sell unit to Eli Lilly cleared EU regulators today cleared the proposed sale of the animal health business of Swiss pharmaceutical giant Novartis to US group Eli Lilly. Business • 03 Oct 14
Novartis in deals with GSK and Eli Lilly Novartis is transforming its business by exchanging certain assets with GlaxoSmithKline and divesting its animal health business to Eli Lilly. Business • 22 Apr 14
Novartis in deals with GSK and Eli Lilly Novartis is transforming its business by exchanging certain assets with GlaxoSmithKline and divesting its animal health business to Eli Lilly. Business • 22 Apr 14
